Showing results (111-120 of 194) with videos related to
Sort By:
Pageof 20
British Journal of Haematology|February 25, 2025
Outcomes and prognostic factors associated with relapse after haploidentical stem cell transplantation for paediatric T-cell acute lymphoblastic leukaemiaChen Zhao, Meng-Yu Xiao, Feng Zhang, et al.Scientific Reports|February 13, 2020
Prevalence and risk factors of having antibodies to class I and II human leukocyte antigens in older haploidentical allograft candidatesLe-Qing Cao, Meng Lv, Lan-Ping Xu, et al.Blood Science (Baltimore, Md.)|September 27, 2024
Pre-transplantation levels of lysine (K)-specific methyltransferase 2A (KMT2A) partial tandem duplications can predict relapse of acute myeloid leukemia patients following haploidentical donor hematopoietic stem cell transplantationDao-Xing Deng, Xiao-Hang Ma, Ze-Hua Wu, et al.International Journal of Cancer|July 1, 2016
Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemiaXiao-Dong Mo, Bao-Lin Tang, Xiao-Hui Zhang, et al.Annals of Hematology|January 3, 2021
Prognosis and risk factors for central nervous system relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaQi Chen, Xiao-Lu Zhu, Xin Zhao, et al.Journal of Hematology & Oncology|July 6, 2017
Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysisYing-Jun Chang, Yu Wang, Yan-Rong Liu, et al.Journal of Hematology & Oncology|April 2, 2020
Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized studyYing-Jun Chang, Yu Wang, Lan-Ping Xu, et al.Clinical and Experimental Immunology|May 13, 2022
CMV infection combined with acute GVHD associated with poor CD8+ T-cell immune reconstitution and poor prognosis post-HLA-matched allo-HSCTZe-Ying Fan, Ting-Ting Han, Wei Zuo, et al.Bone Marrow Transplantation|January 26, 2022
Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort studyLi-Ping Yang, Peng Zhao, Ye-Jun Wu, et al.Bone Marrow Transplantation|April 20, 2020
Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomesQi Chen, Xin Zhao, Hai-Xia Fu, et al.Pageof 20